RICE HALL JAMES & ASSOCIATES, LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1230765
San Diego, CA
Position in XERS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,382,264
+$926,082 QoQ
Shares Held
300,791
+19.8% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#57
of 238 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RICE HALL JAMES & ASSOCIATES, LLC holds $193,433,636 across 12 Drug Manufacturers - Specialty & Generic names. XERS ranks #10 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
624,928 | $39,964,145 | |
| 2 | PBH |
Prestige Consumer Healthcare Inc.
|
689,692 | $32,601,740 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
2,332,043 | $23,320,430 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
490,221 | $22,800,178 | |
| 5 | ALKS |
Alkermes plc.
|
390,866 | $20,481,378 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
100,195 | $16,886,865 | |
| 7 | HROW |
Harrow, Inc.
|
387,545 | $16,459,036 | |
| 8 | EOLS |
Evolus, Inc.
|
1,289,888 | $8,951,822 |
All Filings in XERS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,382,264 | 300,791 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,456,182 | 251,066 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||